Generic drugs were introduced decades ago as a free-market alternative to expensive name brands, in contrast to Europe’s government-negotiated system. But although we assume generic versions are identical to their name-brand counterparts, they can differ in important ways. And as the price of generics has spiked, legislators and others are questioning the role of this multibillion-dollar industry in our health care system.

Guests

  • Jeremy Greene MD; Professor of Medicine and the History of Medicine, Johns Hopkins University School of Medicine; Author, “Generic: The Unbranding of Modern Medicine.”

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Redressing Segregation In Maryland’s Public Higher Education

Thursday, Nov 16 2017The federal court judge who ruled that Maryland's public universities were unlawfully segregated rejected solutions proposed by the state's Higher Education Commission and a group representing a coalition of Maryland Historically Black Colleges and Universities for redressing that segregation. We get an update on the case.